• Methylprednisolone Tablet

    Free

    Product Composition & Available Strengths

    We supply Methylprednisolone in a comprehensive, internationally standardized range of strengths to facilitate both low-dose chronic maintenance and the high-dose taper packs mandatory in clinical steroid therapy.

    Active Ingredient MonographAvailable StrengthsFormulation Matrix Delivery SystemPrimary Clinical Target
    Methylprednisolone USP / BP / IP4 mgOral Solid Uncoated Tablet (Cross-scored for micro-titration)Baseline Dose / Tapering: For rheumatoid arthritis maintenance and step-down dose regimens.
    Methylprednisolone USP / BP / IP8 mgOral Solid Uncoated Tablet (Cross-scored for micro-titration)Intermediate Management: For moderate asthma exacerbations and chronic dermatological conditions.
    Methylprednisolone USP / BP / IP16 mgOral Solid Uncoated Tablet (Cross-scored for flexible division)High-Potency Control: For acute autoimmune flares, immunosuppression in organ transplants, and oncology support.